Cell and Gene Therapies in the US Vs the EU Top Five Areas of Differentiation
「細胞・遺伝子治療薬（CGT）やその他の複雑な生物製剤の場合、米国とEUの規制プロセスは、単に管轄の監督だけでなく、様々な点で異なります。
Added Date:
2022-05-23Filters:
| Filter Category | Filter Values |
|---|---|
| Specialty |
|
| Month |
|
| Year |
|
| Language |
|
| Capability |
|
| Asset Type |
|
| Country |
|
| Region |
|
| Content Category |
|
| Market Category |
|
Country Availability:
()